Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS)
Status:
Active, not recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, single-arm, phase II clinical trial to evaluate the
efficacy and safety of INCMGA00012 in Advanced Penile Squamous Cell Carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
MedSIR
Collaborators:
Incyte Biosciences International Sàrl Incyte Corporation